Can a UK AI start-up qualify for the new £3.1 million Frontier AI fund?
Innovate UK has opened a tightly scoped feasibility competition for UK SMEs. Projects must cost £150,000 to £250,000, last no more than three months and resolve a defined technical uncertainty; the published guidance warns that similar calls can have a 2% success rate.
The short version
- What happened
- The call is limited to a single UK-registered micro, small or medium-sized enterprise; consortium partners and subcontractors are not allowed.
- Who it affects
- Founders must fund part of the project, fit the experiment into a short window and accept a highly competitive selection process.
- What remains unproven
- The source is the funder's own competition guidance; no applications have closed, been assessed or received awards.
Keep in mind
The source is the funder's own competition guidance; no applications have closed, been assessed or received awards.
The stated 2% success chance comes from experience with similar competitions, not a denominator from this newly opened call.
The £3.1 million is a maximum competition allocation, not an award to one business, and it may be adjusted.
Later phases are conditional on separate approvals and competitions, so their possible scale should not be treated as committed funding.
Source analysis · 2 linked sources. Primary analysed source date: 1 October 2026. Earliest linked supporting source: 18 March 2025.
Read the full report · 6 min The evidence, methods, implications and limitations
The call is for one SME solving one bounded uncertainty
Innovate UK opened Frontier AI: SME Champions, Phase 1 on 1 October with up to £3.1 million available for short feasibility and industrial-research projects. A lead applicant must be a UK-registered micro, small or medium-sized enterprise working alone. It may submit only one application, cannot bring in consortium partners and cannot use subcontractors. Project work must be carried out in the United Kingdom, most of the funding must be spent there and the applicant must intend to exploit the results there.
The commercial filter is unusually explicit. An application must identify a serviceable market, show ownership or rights over background intellectual property, name a defensibility route and describe one key technical uncertainty that the project will resolve. AI must be the core technical contribution and main source of operational advantage, rather than a thin analytics layer added to a hardware or non-AI product. The starting technology-readiness level must be between one and three.[1]
Budget, grant rate and calendar need to fit before the idea does
Total eligible project costs must fall between £150,000 and £250,000. The published grant rate is up to 70% of eligible costs for a micro or small organisation and up to 60% for a medium-sized organisation. That means an applicant should plan for its own share of the costs and for cash-flow timing rather than treating the headline £3.1 million as money available to one company. The £3.1 million is the total competition allocation and remains subject to a sufficient number of high-quality applications.
Projects must last between one and three months, start by 1 April 2027 and finish by 30 June 2027. Applications close at 11:00 UK time on 11 November 2026, with decisions expected on 26 January 2027. Innovate UK also warns that experience from similar competitions suggests a 2% chance of success. That is not a forecast produced from this call's applicant denominator, which does not yet exist; it is the funder's caution based on comparable competitions.[1]
Four themes define what counts as Frontier AI here
Applicants must select at least one specified priority within four themes. The first covers AI-enabled health and life sciences, including predictive healthcare, medicines discovery, medicines manufacturing and genomics. The second covers AI for advanced materials, including physics-informed machine learning, generative material prediction and uncertainty-aware characterisation. The third covers secure AI for national security and defence, including multi-source decision systems and resilient edge intelligence. The fourth covers AI safety and assurance, including runtime controls for agents, dynamic evaluations, formal verification and adaptive adversarial testing.
The breadth of those themes should not be mistaken for a general innovation voucher. The call excludes projects that cannot quantify a market, cannot establish IP rights, do not identify a defensibility route, or make AI secondary to another product. It also excludes fully autonomous targeting. A credible proposal therefore needs a narrow experiment with pre-defined metrics, not a broad promise to build a platform across several sectors.[1]
The required output is evidence, not a finished product
Phase 1 must produce a proof-of-concept prototype for the whole stack, a core architecture or a critical subsystem, alongside a validation method and evidence of technical novelty. The final technical white paper must report progress, quantified results against pre-defined success criteria, test conditions, remaining risks, a defensibility plan, readiness for Phase 2 and business-scaling assumptions. Synthetic or simulated data may be used, but the applicant must explain how the work would reach state-of-the-art performance or a genuinely new capability.
For founders, the practical test is whether the uncertainty can be answered honestly in three months and within the cost range. Useful metrics depend on the domain: sensitivity and false-positive rates for a health system; prediction error and out-of-distribution behaviour for materials; interruption reliability and bypass rate for agent controls; latency, power and robustness for edge systems. A benchmark without a relevant baseline, sample size and failure analysis would not show that the approach is commercially or technically defensible.[1][2]
Phase 2 is a possibility, not committed follow-on capital
Only successful Phase 1 projects will be eligible to enter a later Phase 2 competition. Innovate UK says Phase 2 could support demonstrators lasting up to 12 months with costs up to £1 million and an expected two-point rise in technology readiness. But the guidance also says Phase 2 and Phase 3 depend on business-case approvals, Phase 1 outcomes and separate competitions. Applicants should not model that money as awarded or automatic.
The call becomes easier to assess after awards are published. Confidence that it expands the UK frontier-AI pipeline would rise with the number of eligible applications, awards by theme and region, grant values, applicant co-funding, milestone results, follow-on investment and projects that reach deployment. It would weaken if awards cluster narrowly, if Phase 2 does not materialise, or if technical white papers omit negative results. Today the verified development is the opening of a competitive public funding route, not proof that it will create successful companies or safer systems.[1]